Author Details

Польшина, Наталья Ивановна

Issue	Section	Title	File
Vol 24, No 4 (2022)	CLINICAL ONCOLOGY	Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study	(Rus)
Vol 26, No 1 (2024)	Articles	Final data on the eﬃcacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world eﬃcacy of prolgolimab in patients with metastatic melanoma in Russia	(Rus)
Vol 26, No 1 (2024)	Articles	Toxicity and safety of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell cancer: The Russian phase IV observational study	(Rus)
Vol 26, No 3 (2024)	Articles	Retrospective analysis of the safety and efficacy of Pembroria® during non-medical switching from the original drug Keytruda® in patients with advanced malignancies of various localizations in real clinical practice	(Rus)
Vol 26, No 3 (2024)	Articles	The combination of lenvatinib and pembrolizumab in the treatment of patients with metastatic kidney cancer and factors of poor prognosis: experience of clinics in Moscow: A prospective observational study	(Rus)
Vol 26, No 4 (2024)	Articles	Interim results analysis of the PERFECTION observational study in patients with metastatic non-small cell lung cancer	(Eng)
Vol 27, No 3 (2025)	Articles	Real-world efficacy and safety of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: Updated data from a Russian observational study	(Rus)